According to health experts, getting the flu vaccine can help reduce hospitalizations and death. A 2023 CDC study showed that ...
The vaccine FluMist, manufactured by MedImmune, which was acquired by AstraZeneca in 2007, was first approved by the FDA in 2003 for individuals between five and 49 years of age. Its approval has ...
People ages 6 months and older should receive a vaccine every year. It is also recommended that people over 65 years old get ...
FluMist is a nasal spray manufactured by AstraZeneca that has been used to protect against influenza in the United States ...
The FDA has approved FluMist nasal spray as the first at-home flu vaccine. People aged 18 and older can now self-administer ...
On Friday, the US Food and Drug Administration approved UK pharma major AstraZeneca’s (LSE: AZN) FluMist for self- or ...
Health data show that COVID-19 still surpasses all other infectious respiratory illnesses as a cause of severe illness, ...
First Influenza Vaccine That Does Not Need to be Administered by a Health Care Provider ...
FluMist, a needle-free nasal spray influenza vaccine, has been approved by the FDA for self-administration in the US, making ...
(IN BRIEF) FluMist, a needle-free nasal spray influenza vaccine, has been approved by the FDA for self-administration in the US, making it the first flu vaccine of its kind to be used at home. Adults ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback